Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
thebusinessmagazine
57m
Oxford Instruments names Paul Fry as CFO designate under succession plans
Abingdon-based Oxford Instruments told investors that experienced executive Paul Fry will be appointed as its chief financial ...
20m
Guillain-Barre Syndrome explained as 2 RSV vaccines flag neurological 'risk'
As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...
12m
on MSN
RSV vaccines to carry neurological disorder risk warning after new research
On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Court allows report release
SCOTUS rejects Trump’s bid
'Pizzagate' gunman killed
Teen arrested with a gun
Illinois passes Karina's Bill
Peacock president to exit
DOJ sues Pennsylvania city
Grizzly bears stay protected
1.2M-year-old ice core
Appeals her disqualification
Ex-FBI informant gets 6 yrs
Settles opioid lawsuit
Mortgage rate inches up
EC fined for data breach
Santos' sentencing delayed
Presidential palace attack
Sworn in as NH governor
Russian strike in Ukraine
Crime leader pleads guilty
Oscar nominations delayed
Wycheck had CTE
ACLU sues DeSantis
Freed after brief detention
Lebanon's new president
Judge scraps Title IX rules
New Orleans hires Bratton
Clarifies Siri privacy stance
La Nina finally arrives
Bill to sanction ICC OK'd
Related topics
GSK
New York Stock Exchange
Food and Drug Administration
Guillain–Barré syndrome
Breakthrough therapy
Feedback